Quarter Ended Sep 30, 2022
Net sales were $104.5 million compared to $114.7 million (down 2% in constant currency).
GAAP net income was $0.2 million, or $0.00 per diluted common share, compared to $5.5 million, or $0.24 per diluted common share.
Adjusted EBITDA was $6.8 million compared to $12.9 million.
For complete information regarding our financials, see our periodic filings.